CRS Clinical Research Services, an early-phase Contract Research Organization (CRO), has appointed Dr. Elisabeth Lackner as Chief Executive Officer (CEO), effective immediately.   Tasked with leading the organization’s future strategic direction, Lackner aims to drive internationalization of the business and to enhance the Company’s service portfolio with a focus on quality, innovation, and client satisfaction.   Lackner commented: “I am honored to join this great management team and t...